&w=3840&q=100)
Indiqube Spaces IPO invites bids: GMP up 10%; should you apply?
At the upper end, the company aims to raise ₹852.53 crore through the offering, which comprises a fresh issue of 27.4 million equity shares worth ₹650 crore and an OFS with promoters Meghna Agarwal and Rishi Das divesting up to 2.1 million equity shares, aggregating up to ₹50 crore. Notably, Indiqube Spaces has already raised ₹314.32 crore from anchor investors in the bidding that concluded on July 22.
Meanwhile, the brokerages remain optimistic about the public offering, citing a favourable long-term outlook. Before delving into the brokerage reports, let's have a look at the key details of the Indiqube Spaces IPO:
Indiqube Spaces IPO price band, lot size
Indiqube Spaces has set a price band of ₹225-237 per share for the IPO. The lot size is 63 shares, allowing investors to bid for a minimum of one lot (63 shares) at ₹14,931.
A retail investor can, however, bid for a maximum of 13 lots or 869 shares of Indiqube Spaces IPO with an investment of ₹1,94,103.
Indiqube Spaces IPO grey market premium (GMP)
The unlisted shares of Indiqube Spaces were commanding a decent premium in the grey markets ahead of the opening of their public issue on Wednesday. Sources tracking unofficial market activity revealed that Indiqube Spaces shares were trading at ₹260 apiece, reflecting a grey market premium (GMP) of ₹23 or 9.70 per cent over the upper price band of ₹237.
Indiqube Spaces IPO timelines
Indiqube Spaces IPO will remain open for subscription until Friday, July 25, 2025. Following that, the basis of allotment of Indiqube Spaces IPO shares is expected to be finalised on Monday, July 28, 2025, and shares will be credited to successful allottees' demat accounts on Tuesday, July 29, 2025.
The tentative listing date for Indiqube Spaces shares on the BSE and NSE is Wednesday, July 30, 2025.
Indiqube Spaces IPO registrar, lead manager
MUFG Intime India (Link Intime) has been appointed as the registrar for the Indiqube Spaces IPO, while ICICI Securities acts as the book-running lead manager for the issue.
Indiqube Spaces IPO objectives
The company will not receive any proceeds from the OFS, as those will go to the selling promoters. The company, however, proposes to utilise the proceeds from the fresh issue for funding capital expenditure towards the establishment of new centers, as well as for the repayment/pre-payment, in full or in part, of certain borrowings availed by the company. Indiqube Spaces will further use the proceeds from the fresh issue for general corporate purposes.
Should you subscribe to Indiqube Spaces IPO?
Anand Rathi Research - Subscribe for long-term
Analysts at Anand Rathi Research team have recommended the investors to subscribe to the public offering for a long-term perspective citing that the issue is fully priced. "At the upper price band, the company is valuing at P/S of 4.7x with EV/EBITDA of 14.6x and market cap of ₹4,977.1 crore post issue of equity shares," wrote the analyst in a research note.
The company plans to expand its commercial real estate portfolio further, both in scale and geographical reach across the country. "The company's integrated tech platform, MiQube, connects clients, employees, and service partners to streamline office operations, enhance efficiency, and improve overall workspace experience."
About Indiqube Spaces
Indiqube Spaces is a managed workplace solutions company offering comprehensive, sustainable, and technology-driven workplace solutions. The company offers a diverse solutions range from providing large corporate offices to small branch offices for enterprises and transforming the workplace experience of their employees by combining interiors, amenities, and a host of value-added services which are incremental to the workspace leasing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
13 minutes ago
- Business Standard
Laurus rallies 6%, hits new high on strong Q1; brokerages see more upside
Laurus Labs share price today Shares of Laurus Labs hit a new high of ₹889.3, surging 6 per cent on the BSE in Monday's intra-day trade in an otherwise subdued market after the company reported strong earnings for the June 2025 quarter (Q1FY26). The BSE Sensex was up 0.06 per cent at 81,512 at 10:20 AM. In the past one month, the stock of pharmaceutical company has outperformed the market by soaring 27 per cent, as compared to 2.7 per cent decline in the BSE Sensex. It has zoomed 128 per cent from its 52-week low of ₹390.30 on August 8, 2024. Laurus Labs - Q1FY26 performance, outlook Laurus delivered a solid performance in Q1, in line with market expectations. The management said they are pleased to see sustained growth momentum fueled by increasing uptake in the contract development and manufacturing organisation (CDMO) deliveries and healthy business fundamentals. The company has achieved revenues of ₹1,570 crore, representing 31 per cent year-on-year (YoY) growth and earnings before interest, taxes, depreciation, and amortization (EBITDA) of ₹389 crore, representing 127 per cent growth. The EBITDA margins improved substantially to 24.8 per cent, from 14.3 per cent in Q1FY25, supported by continuing operating leverage. Gross margins stood strong at 59.4 per cent due to favorable CDMO mix and ongoing process improvement initiatives. Profit after tax stood ₹161.1 crore, driven by a favorable product mix and strong operational performance. Laurus has made a healthy progress to start the year with increasing contributions from the CDMO business and continued advancement of pipeline projects, supported by Generic Formulation (FDF). The management said the company is moving ahead with strong focus on commercial execution realizing the full potential from promising pipeline opportunities, business development and rapidly enhancing scale and technology capabilities. ALSO READ | Brokerages firm see more upside in stock price of Laurus The CDMO growth was driven by several mid-to-late stage NCE deliveries and steady increase in sales from new manufacturing assets. Out of ₹3,200 core of capex that the company has incurred during FY22-25, almost ~75 per cent was earmarked towards active pharmaceutical ingredient (API) / CDMO. The company is now getting the benefit of the same as the CDMO quarterly run rate has gone up from ₹220-250 crore to ₹450-500 crore in two years. The CDMO contribution has also gone up from ~16 per cent to 33 per cent which has led to a significant margin expansion. ICICI Securities said they continue to monitor progress on these driving factors which in a way are expected to change the business mix in favour of these segments in lieu of anti-retroviral (ARV). Analysts at Choice Equity Broking believe Laurus is evolving from a traditional Generics player to a CDMO (Synthesis)–led model, with the segment targeted to reach ~50 per cent of revenues in the long term. Given the higher-margin profile of CDMO and operating leverage as new manufacturing assets ramp and current underutilization narrows, the brokerage firm expects sustained margin expansion. Analysts maintain 'buy' rating on the stock with revised target price of ₹1,025 against previous target price of ₹750. Motilal Oswal Financial Services raise earnings estimates by 16 per cent/7 per cent for FY26/FY27, factoring in strong tailwinds in CDMO segment led by 110+ active pipeline projects/ramp-up from new manufacturing facilities, additional contracts in generic FDF segment, and margin expansion from scale. Considering a 63 per cent earnings compounded annual growth rate (CAGR) over FY25-27, the brokerage firm value Laurus at 56x 12M forward earnings to arrive at a target price of ₹970. Reiterate BUY.
&w=3840&q=100)
Business Standard
13 minutes ago
- Business Standard
Shriram Finance rises 3% on Q1 results; Should you buy, sell or hold?
Shriram Finance share price today: Shares of Non-Banking Financial Company (NBFC) Shriram Finance rose nearly 4 per cent on Monday, on the NSE, after the company posted its Q1 results. The stock touched an intra-day high of ₹637.9. At 10:05 AM, Shriram Finance's share price was trading 3.52 per cent higher at ₹637.50 per share on the NSE. In comparison, NSE Nifty50 was down 0.07 per cent at 24,820 levels. The market capitalisation of the company stood at ₹1.19 trillion. Shriram Finance Q1 results Shriram Finance's standalone net interest income for the first quarter ended June 30, 2025, rose 12.55 per cent to ₹6,026.43 crore compared to ₹5,354.47 crore in the year-ago period. The company's profit after tax (PAT) increased by 8.84 per cent to ₹2,155.73 crore as against ₹1,980.59 crore recorded in the corresponding quarter of the previous year. It reported earnings per share of ₹11.46, up 8.73 per cent from ₹10.54 in Q1FY25. Shriram Finance Q1 results analysis: JM Financial According to analysts at JM Financial, Shriram Finance's well-diversified and predominantly secured product portfolio continues to deliver strong growth and profitability post-merger. However, citing the near-term pressure on net interest margins NIMs, the brokerage revised its FY26 NIM estimate downward by 34 basis points (bps), leading to a 3 per cent to 5 per cent cut in EPS estimates for FY26–28E. "We now build in average RoA/RoE of 3 per cent/16 per cent over FY26–27E and maintain our 'Buy' rating with a revised target price of ₹730, valuing the stock at 1.9x FY27E BVPS," the brokerage said. ICICI Securities According to ICICI Securities, the company's core operating performance in the June 2025 quarter remained strong with NII growth at 4 per cent Q-o-Q/10 per cent Y-o-Y and a sequential easing in credit cost to 1.9 per cent compared to 2.4 per cent Q-o-Q. "Amid a challenging operating environment, especially in certain segments such as MSME, entry-level PV and used CV, credit cost moderation in Q1FY26 reflects its business resiliency and risk management," the brokerage said in a note. It further highlighted management commentary that an uptick in early buckets (Stage-2 assets) is transitory (cashflow mismatch at the borrower level is due to seasonality and not stress); hence, it expects asset quality (mainly Stage-3 assets) to remain strong in FY26. ICICI Securities has maintained a 'Hold' on Shriram Finance with an unchanged target of ₹640.
Economic Times
13 minutes ago
- Economic Times
IEX shares slide 9% as market coupling fears continue to drag, brokerages cut targets
Shares of Indian Energy Exchange (IEX) fell as much as 8.9% on Monday, July 28, to Rs 132.15 on BSE, as renewed selling pressure weighed on the stock amid persistent concerns over market coupling — a regulatory shift that threatens the company's dominance in power trading. ADVERTISEMENT The decline comes after IEX shares rebounded 13% on Friday, following the release of strong Q1 FY26 results. That rally offered temporary respite to investors after the stock's record single-day plunge of nearly 30% on Thursday, when the Central Electricity Regulatory Commission (CERC) approved market coupling – a move widely viewed as a structural threat to the company's business model. On Thursday, the sell-off triggered massive trading volumes, with 12.77 crore shares worth Rs 1,740 crore changing hands, surpassing the combined volumes of all 16 earlier trading sessions in July. Over 43.75% of the shares traded on the NSE were marked for delivery, indicating a sharp churn in investor positions. Brokerages have flagged the CERC's order as a significant threat to IEX's pricing power and market said the regulation 'disrupts IEX's monopoly in the DAM market by introducing uniform price discovery across exchanges. This levels the playing field, impacting IEX's moat of price determination.' ADVERTISEMENT The brokerage expects IEX's share in the DAM and RTM segments (currently 99% of FY25 volumes and 80–85% of sales) to fall to 70% by FY27. 'A price war-led trading margin cut is likely, from 4p/kWh to 3.5p/kWh by FY28E,' Nuvama said, retaining a 'reduce' rating with a target price of Rs 133, down from Rs said that market coupling will accelerate IEX's market share losses, projecting a decline from over 80% in FY25 to 50% by FY28. 'The market coupling threat has become a reality… The regulation has taken away [IEX's liquidity advantage] as all power exchanges will have a uniform clearing price,' it said. Jefferies cut its price target to Rs 105 from Rs 150 and maintained an 'underperform' rating. ADVERTISEMENT Elara Capital also flagged 'significant pressure on IEX,' noting that CERC has approved phased implementation of market coupling, starting with the day-ahead market (DAM) by January 2026. 'This poses a major threat to Indian Energy Exchange's dominance, as market coupling could shift volume to rival exchanges,' it said, adding that IEX could be forced to lower trading margins to retain market Q1 FY26 performance briefly supported the stock last week. The company reported a 25% year-on-year (YoY) rise in consolidated net profit to Rs 120 crore, compared to Rs 96 crore a year earlier. Revenue climbed 19% YoY to Rs 184.2 crore, driven by robust trading activity. Electricity volumes rose 14.9% YoY to 32.4 billion units, while Renewable Energy Certificates (RECs) surged 149.3% YoY to 52.7 lakh units. ADVERTISEMENT 'The company is currently undertaking a detailed impact assessment of the implications of [market coupling] and will keep stakeholders informed of any further developments,' IEX said in its post-results analysts caution that earnings momentum could soften as regulatory reforms reshape market dynamics. 'With the core business model under pressure and limited clarity on long-term profitability, markets have rightly reacted. For IEX, the days of monopoly-like pricing power may now be history,' said Harshal Dasani, Business Head at INVasset PMS. Also read | Understand 'Market Coupling Approved' before reacting to IEX stock price movement and making any decision (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
